Skip to main content
. Author manuscript; available in PMC: 2017 Feb 12.
Published in final edited form as: Breast Cancer Res Treat. 2016 Feb 12;155(3):579–588. doi: 10.1007/s10549-016-3706-2

Table 4. Cumulative Average DASH Score and Risk of Breast Cancer by Molecular Subtype.

DASH score p for trend P-het
Q1 Q2 Q3 Q4 Q5
Range (7.0-19.6) (19.7-22.2) (22.3-24.6) (24.7-27.0) (27.1-38.0)
Luminal A (n=1,394) 0.12
# cases/person-years 248/352,753 246/355,877 295/351,637 297/353,650 308/354,837
Age-adjusted HR (95% CI) 1.00 (ref) 0.93 (0.78, 1.11) 1.13 (0.95, 1.34) 1.09 (0.92, 1.29) 1.06 (0.89, 1.26) 0.23
Multivariate HRa (95% CI) 1.00 (ref) 0.90 (0.75, 1.08) 1.08 (0.91, 1.29) 1.04 (0.87, 1.24) 0.99 (0.83, 1.19) 0.63
Luminal B (n=569)
# cases/person-years 98/352,891 106/356,004 115/351,792 121/353,800 129/355,009
Age-adjusted HR (95% CI) 1.00 (ref) 0.95 (0.72, 1.26) 1.02 (0.77, 1.34) 1.06 (0.81, 1.39) 1.10 (0.84, 1.45) 0.34
Multivariate HRa (95% CI) 1.00 (ref) 0.91 (0.69, 1.20) 0.96 (0.73, 1.27) 1.00 (0.76, 1.32) 1.04 (0.78, 1.38) 0.59
Her2 type (n=139)
# cases/person-years 41/352,952 22/356,085 17/351,885 33/353,882 21/355,107
Age-adjusted HR (95% CI) 1.00 (ref) 0.53 (0.31, 0.89) 0.36 (0.20, 0.65) 0.73 (0.45, 1.16) 0.43 (0.25, 0.73) 0.01
Multivariate HRa (95% CI) 1.00 (ref) 0.52 (0.31, 0.89) 0.37 (0.21, 0.66) 0.72 (0.45, 1.18) 0.44 (0.25, 0.77) 0.02
Basal-like (n=225)
# cases/person-years 45/352,940 38/356,074 47/351,850 39/353,881 39/355,085
Age-adjusted HR (95% CI) 1.00 (ref) 0.87 (0.56, 1.35) 1.12 (0.74, 1.69) 0.89 (0.58, 1.39) 0.87 (0.56, 1.36) 0.58
Multivariate HRa (95% CI) 1.00 (ref) 0.86 (0.55, 1.33) 1.04 (0.68, 1.59) 0.83 (0.53, 1.30) 0.77 (0.48, 1.22) 0.26
Unclassified (n=74)
# cases/person-years 14/352,970 15/356,097 8/351,891 12/353,905 18/355,116
Age-adjusted HR (95% CI) 1.00 (ref) 1.13 (0.54, 2.37) 0.60 (0.25, 1.45) 0.92 (0.42, 2.01) 1.36 (0.66, 2.80) 0.55
Multivariate HRa (95% CI) 1.00 (ref) 1.20 (0.57, 2.54) 0.61 (0.25, 1.49) 0.94 (0.42, 2.12) 1.37 (0.64, 2.94) 0.56
a

Multivariate model adjusted for BMI at age 18 (continuous), weight change since age 18 in kgs (continuous), physical activity in MET hours/week (<3, 3-<9, 9-<18, 18-<27, 27+), energy intake in kilocalories/day (continuous), parity/age at first birth (nulliparous, 1-2 children <25 years, 1-2 children 25-29 years, 1-2 children 30+ years, 3+ children <25 years, 3+ children 25-29 years, 3+ children 30+ years), menopausal hormone use (premenopausal, postmenopausal never/past/current/unknown), alcohol intake (Nondrinker, 0.1-<5g/day, 5-<10 g/day, 10-<20g/day, 20+ g/day), oral contraceptive use (never/ever), age at menarche (<12, 12, 13, 14, 15+ years), age at menopause (continuous), family history of breast cancer (yes/no), and benign breast disease diagnosis (yes/no).